5.740USD+0.53%Mkt Cap: 645.64M $P/E: —1d ago
Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform…
Industry Peers
Health Information Servicesvs Health Information Services
P/B
Avg
1M Perf
Lower
$31.19BUSDP/E 34.0
$13.85BUSDP/E 91.6
$10.90BUSD
$8.10BUSDP/E 36.2
$6.85BUSD
$5.08BUSD
$4.59BUSDP/E 35.7
$3.43BUSDP/E 159.9
$2.34BUSD
$2.06BUSDP/E 102.8
$1.68BUSD
$1.36BUSD
$1.27BUSD
$1.11BUSD
$1.04BUSDP/E 51.3
$877.77MUSDP/E Infinity
$849.29MUSDP/E 43.4
$756.89MUSDP/E 35.7
$685.69MUSDP/E 69.4
$543.28MUSDP/E 12.8
$565.30MUSD
$533.09MUSD
$516.62MUSD
$507.08MUSDP/E 57.7
$458.45MUSDP/E 26.1
$419.03MUSDP/E 23.5
$393.73MUSDP/E 90.5
$371.17MUSD
$334.10MUSD
$249.14MUSDP/E 15.2
$237.46MUSD
$218.06MUSDP/E 17.7
$169.22MUSD
$151.50MUSDP/E 30.1
$148.04MUSDP/E 39.9
$154.55MUSD
$134.30MUSDP/E Infinity
$119.16MUSDP/E 17.6
$114.15MUSDP/E 25.5
$93.91MUSDP/E 17.0
$90.94MUSD
$65.63MUSDP/E 11.3
$65.05MUSDP/E 23.6
$55.64MUSD
$52.43MUSD
$47.87MUSDP/E 57.6
$45.06MUSDP/E 43.0
$40.30MUSD
$38.36MUSD
$23.19MUSDP/E 55.5
$24.86MUSDP/E 24.0
$23.68MUSD
$19.89MUSD
$13.45MUSD
$13.30MUSD
$12.94MUSD
$11.13MUSD
$9.78MUSDP/E 15.1
$7.61MUSD
$7.54MUSD
$5.90MUSD
$5.49MUSD
$3.76MUSDP/E Infinity
$3.95MUSDP/E 0.0
$3.52MUSD
$3.21MUSD
$2.78MUSD
$2.16MUSDP/E Infinity
$544.4KUSDP/E 0.0
$355.5KUSD
$256.9KUSD
—
—
CRY
GraniteShares YieldBOOST CRCL ETF—
—
EYES
Corgi Data & Surveillance ETF—P/E 31.8
Indicators:|
Key Statistics
Company
Market Cap645.64M $
Enterprise Value1.45B $
Revenue (TTM)1.89B $
Gross Profit399.88M $
Net Income (TTM)-534.51M $
Revenue/Share16.66 USD
Last Price5.740 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees4.2K
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)14.08
PEG1.93
EV/EBITDA19.54
EV/Revenue0.77
P/S0.32
P/B1.54
EPS (TTM)-4.68
EPS (Forward)0.38
52W Range
2.09537% of range12.06
52W High12.06 USD
52W Low2.095 USD
Profitability
Gross Margin21.31%
Oper. Margin-2.04%
EBITDA Margin3.94%
Profit Margin-28.49%
ROE-128.74%
ROA-28.14%
Growth
Revenue Growth2.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF38.84M $
CapEx (TTM)34.09M $
FCF Margin2.80%
FCF Yield8.20%
Net Debt843.40M $
Net Debt/EBITDA11.34
Balance Sheet
Debt/Equity2.38
Current Ratio1.32
Quick Ratio1.20
Book Value/Sh3.524 USD
Cash/Share1.263 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.885 USD
Upside (mean)+2.5%
Target Range3.000 USD – 8.000 USD
$3.000+2.5% to mean$8.000
# Analysts13
Ownership
Shares Out.112.48M
Float94.02M
Insiders2.49%
Institutions100.98%
Short Interest
Short Ratio5.9d
Short % Float13.11%
Short % Out.12.97%
Shares Short14.58M
Short (prev mo.)14.94M
Technical
SMA 504.095 (+40.2%)
SMA 2004.523 (+26.9%)
Beta0.83
S&P 52W Chg20.05%
Avg Vol (30d)2.06M
Avg Vol (10d)2.69M
Technical Indicators
RSI (14)69.7
MACD0.4325
MACD Signal0.3615
MACD Hist.+0.0710
BB Upper5.963 USD
BB Middle4.962 USD
BB Lower3.961 USD
BB Width40.35%
ATR (14)0.3532 USD
Vol Ratio (20d)1.12x